Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package (LIFT-UP): Randomized Controlled Trial of In-facility Fortification of Human Milk in India and Malawi

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other, Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of the LIFT-UP randomized controlled trial is to evaluate the efficacy of feeding routinely and fortified human milk using a standardized clinical protocol to very low birthweight (VLBW) or very preterm (VPT) infants in the NICU compared to not feeding routinely fortified human milk using the standardized clinical protocol. The primary research question is: Will VLBW or VPT infants in the NICU who are fed fortified human milk using a standardized feeding protocol have better growth outcomes by facility discharge and at 3 months of age, less illness by discharge, and decreased mortality by discharge and at one month compared to those who are not routinely fed fortified human milk using the same feeding protocol?

Eligibility
Participation Requirements
Sex: All
Maximum Age: 2 days
Healthy Volunteers: t
View:

• Very LBW (≤1.5kg)\* or very preterm (≤32 weeks) infants admitted to NICU at study facility within 24 hours of birth for in-born infants and up to 48 hours for out-born\*\*

• Mother and infant alive during screening

• Mother age 18+ years or 16-17 and married (Malawi only)

• Lives within catchment areas of the facility (50km)

• Mother intends to stay in catchment area of the study facility for at least 3 months

• At randomization: Infant receiving at least 60 mL/kg/day of human milk\*\*\*

Locations
Other Locations
India
Ballari Medical College and Research Centre
RECRUITING
Ballary
KLES Dr Prabhakar Kore Hospital & Medical Research Center
NOT_YET_RECRUITING
Belagavi
JJM Medical College
RECRUITING
Davangere
Malawi
Kamuzu Central Hospital
NOT_YET_RECRUITING
Lilongwe
Contact Information
Primary
Ilana Dzuba, MHS
idzuba@ariadnelabs.org
617-384-6555
Backup
Linda Vesel, PhD, MPH
lvesel@ariadnelabs.org
Time Frame
Start Date: 2025-01-16
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 1162
Treatments
Experimental: Routine fortification of human milk with human milk fortifier using a standardized clinical protocol
Enrolled participants in the intervention arm will be exposed to:~* Provision of guideline-driven standard of care specifically for VPT/ VLBW babies~* Encouragement to express breast milk with breast pumps~* Adherence to a clinical guideline including targets for initiation and advancement of breast milk feeding for VPT/ VLBW babies based on birthweight~* Fortification of human milk with HMF~* Adherence to standardized stopping criteria (i.e., stopping adherence to clinical feeding guideline AND stopping routine fortification of human milk)
Active_comparator: No routine fortification of human milk using a standardized clinical protocol
Participants in the control group will have the same exposures as the participants in the intervention group EXCEPT for the human milk consumed will not be fortified with HMF.~* Provision of guideline-driven standard of care specifically for VPT/ VLBW babies~* Encouragement to express with breast pumps~* Adherence to a clinical guideline including targets for initiation and advancement of breast milk feeding for VPT/ VLBW babies based on birthweight~* Adherence to standardized stopping criteria (i.e., stopping adherence to clinical feeding guideline)
Related Therapeutic Areas
Sponsors
Collaborators: PATH, Muhimbili University of Health and Allied Sciences, University of North Carolina, Emory University, Boston Children's Hospital, Brigham and Women's Hospital, Jawaharlal Nehru Medical College
Leads: Harvard School of Public Health (HSPH)

This content was sourced from clinicaltrials.gov